↓ Skip to main content

Myristyl Trimethyl Ammonium Bromide and Octadecyl Trimethyl Ammonium Bromide Are Surface-Active Small Molecule Dynamin Inhibitors that Block Endocytosis Mediated by Dynamin I or Dynamin II

Overview of attention for article published in Molecular Pharmacology, September 2007
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
68 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Myristyl Trimethyl Ammonium Bromide and Octadecyl Trimethyl Ammonium Bromide Are Surface-Active Small Molecule Dynamin Inhibitors that Block Endocytosis Mediated by Dynamin I or Dynamin II
Published in
Molecular Pharmacology, September 2007
DOI 10.1124/mol.107.034207
Pubmed ID
Authors

A. Quan, A. B. McGeachie, D. J. Keating, E. M. van Dam, J. Rusak, N. Chau, C. S. Malladi, C. Chen, A. McCluskey, M. A. Cousin, P. J. Robinson

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
United Kingdom 1 1%
Australia 1 1%
Switzerland 1 1%
Ireland 1 1%
Germany 1 1%
Korea, Republic of 1 1%
Netherlands 1 1%
Unknown 59 87%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 24 35%
Student > Master 14 21%
Researcher 10 15%
Unspecified 6 9%
Student > Doctoral Student 4 6%
Other 10 15%
Readers by discipline Count As %
Agricultural and Biological Sciences 36 53%
Chemistry 9 13%
Unspecified 7 10%
Biochemistry, Genetics and Molecular Biology 6 9%
Medicine and Dentistry 5 7%
Other 5 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 August 2014.
All research outputs
#3,639,707
of 12,527,715 outputs
Outputs from Molecular Pharmacology
#666
of 2,436 outputs
Outputs of similar age
#87,427
of 261,878 outputs
Outputs of similar age from Molecular Pharmacology
#8
of 36 outputs
Altmetric has tracked 12,527,715 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,436 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 261,878 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.